Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Glatting

Showing results (101-110 of 150) with videos related to

Pageof 15
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 5, 2023
Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfallsOleksandra V Ivashchenko, Jim O'Doherty, Deni Hardiansyah, et al.
Nuklearmedizin. Nuclear Medicine|September 11, 2023
Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLCKatharina Deininger, Joel Niclas Raacke, Elham Yousefzadeh-Nowshahr, et al.
Nuclear Medicine and Biology|July 2, 2019
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligandsGordon Winter, Anja Vogt, Luis David Jiménez-Franco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDGAndreas K Buck, Gisela Halter, Holger Schirrmeister, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemiaBernd Neumaier, Felix M Mottaghy, Andreas K Buck, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 29, 2026
Current practice in reporting internal dosimetry for [<sup>177</sup>Lu]Lu-DOTATATE therapy: a systematic reviewOleksandra V Ivashchenko, Jim O'Doherty, Teresa Pérez García-Estañ, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferationInga Buchmann, Andreas T J Vogg, Gerhard Glatting, et al.
Cancers|May 21, 2020
Multi-Modal PET and MR Imaging in the Hen's Egg Test-Chorioallantoic Membrane (HET-CAM) Model for Initial <i>in Vivo</i> Testing of Target-Specific RadioligandsGordon Winter, Andrea B F Koch, Jessica Löffler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Sandra Deisenhofer, Gerhard Glatting, et al.
Cancers|December 30, 2025
Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC ModelGustavo Costa, Elham Yousefzadeh-Nowshahr, Valentina Vasic, et al.
Pageof 15

Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 5, 2023
Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfallsOleksandra V Ivashchenko, Jim O'Doherty, Deni Hardiansyah, et al.
Nuklearmedizin. Nuclear Medicine|September 11, 2023
Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLCKatharina Deininger, Joel Niclas Raacke, Elham Yousefzadeh-Nowshahr, et al.
Nuclear Medicine and Biology|July 2, 2019
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligandsGordon Winter, Anja Vogt, Luis David Jiménez-Franco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDGAndreas K Buck, Gisela Halter, Holger Schirrmeister, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemiaBernd Neumaier, Felix M Mottaghy, Andreas K Buck, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 29, 2026
Current practice in reporting internal dosimetry for [<sup>177</sup>Lu]Lu-DOTATATE therapy: a systematic reviewOleksandra V Ivashchenko, Jim O'Doherty, Teresa Pérez García-Estañ, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferationInga Buchmann, Andreas T J Vogg, Gerhard Glatting, et al.
Cancers|May 21, 2020
Multi-Modal PET and MR Imaging in the Hen's Egg Test-Chorioallantoic Membrane (HET-CAM) Model for Initial <i>in Vivo</i> Testing of Target-Specific RadioligandsGordon Winter, Andrea B F Koch, Jessica Löffler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Sandra Deisenhofer, Gerhard Glatting, et al.
Cancers|December 30, 2025
Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC ModelGustavo Costa, Elham Yousefzadeh-Nowshahr, Valentina Vasic, et al.
Pageof 15